During the past decade, Orion Pharma pharmacology Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Orion Pharma pharmacology Unit" are "Asthma" (2 trials). Many other conditions were trialed in "Orion Pharma pharmacology Unit" in a lesser frequency.

Most popular intervention types in "Orion Pharma pharmacology Unit" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Salmeterol/fluticasone Easyhaler" (2 trials), "Salmeterol/fluticasone Easyhaler with charcoal" (2 trials), "Seretide Diskus" (2 trials) and "Seretide Diskus with charcoal" (2 trials). Other intervention names were less common.

The vast majority of trials in "Orion Pharma pharmacology Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Orion Pharma pharmacology Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Orion Pharma pharmacology Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orion Pharma pharmacology Unit, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Orion Pharma pharmacology Unit has several departments that took part in Clinical trials: "Orion Pharma phase I unit" - 6 trials, "Clinical Pharmacology Unit, Orion Corporation" - 2 trials